Advances in Chronic Kidney Disease
Volume 17, Issue 4 , Pages 293-301 , July 2010

Chronic Kidney Disease and End-Stage Renal Disease in the Elderly Population: Current Prevalence, Future Projections, and Clinical Significance

References 

  1. Blagg CR. The early history of dialysis for chronic renal failure in the United States: A view from Seattle. Am J Kidney Dis. 2007;49:482–496
  2. United States Renal Data System: Excerpts from the United States renal data system—2009 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis. 2010;55(Suppl 1):
  3. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–612
  4. Eckardt KU, Berns JS, Rocco MV, et al. Definition and classification of CKD: The debate should be about patient prognosis–a position statement from KDOQI and KDIGO. Am J Kidney Dis. 2009;53:915–920
  5. Kurella TM, Wadley V, Yaffe M, et al. Kidney function and cognitive impairment in US adults: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Am J Kidney Dis. 2008;52:227–234
  6. Manjunath G, Tighiouart H, Coresh J, et al. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int. 2003;63:1121–1129
  7. Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005;352:2049–2060
  8. Hallan SI, Astor B, Romundstad , et al. Association of kidney function and albuminuria with cardiovascular mortality in older compared to younger individuals: The HUNT II study. Arch Intern Med. 2007;167:2490–2496
  9. Older Americans 2008: Key indicators of well-being. Available at: http://www.agingstats.gov/agingstatsdotnet/Main_Site/Data/2008_Documents/OA_2008.pdf. Cited December 12, 2009
  10. Centers for Disease Control and Prevention. Public health and aging: Trends in aging—United States and worldwide. MMWR. 2003;52:101–106
  11. World population ageing, 1950-2050. New York, NY: Department of Economic and Social Affairs; 2006;
  12. Schneider KM, O'Donnell BE, Dean D. Prevalence of multiple chronic conditions in the United States' Medicare population. Health Qual Life Outcomes. 2009;7:82
  13. Flegal KM, Caroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010;303:235–241
  14. Centers for Disease Control and Prevention. National diabetes fact sheet: General information and national estimates on diabetes in the United States, 2007. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2008;
  15. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension. 2007;49:69–75
  16. Kanjilal S, Gregg EV, Cheng YJ, et al. Socioeconomic status and trends in disparities in 4 major risk factors for cardiovascular disease among US adults, 1971-2002. Arch Intern Med. 2006;166:2348–2355
  17. WHO Global InfoBase: Chronic diseases and their common risk factors. Available at: https://apps.who.int/infobase/report.aspx. Cited December 1, 2009
  18. Stevens LA, Coresh J, Schmid CH, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: A pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis. 2008;51:395–406
  19. Stevens LA, Levey AS. Chronic kidney disease in the elderly–how to assess risk. N Engl J Med. 2005;352:2122–2124
  20. Levey AS, Stevens LA, Coresh J. Conceptual model of CKD: Applications and implications. Am J Kidney Dis. 2009;53(Suppl 3):S4–S16
  21. Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–992
  22. Zhang L, Zhang P, Wang F, et al. Prevalence and factors associated with CKD: A population study from Beijing. Am J Kidney Dis. 2008;51:373–384
  23. Cirillo M, Senigalliesi L, Laurenzi M, et al. Microalbuminuria in nondiabetic adults: Relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: The Gubbio population study. Arch Intern Med. 1998;158:1933–1939
  24. Alexander MP, Patel TV, Farag YM, et al. Kidney pathological changes in metabolic syndrome: A cross-sectional study. Am J Kidney Dis. 2009;53:751–759
  25. Serra A, Romero R, Lopez D, et al. Renal injury in the extremely obese patients with normal renal function. Kidney Int. 2008;73:947–955
  26. Fogo A, Breyer JA, Smith MC, et al. Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: A report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study investigators. Kidney Int. 1997;51:244–252
  27. Meyer TW, Bennett PH, Nelson RG. Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria. Diabetologia. 1999;42:1341–1344
  28. Lindeman RD. Overview: Renal physiology and pathophysiology of aging. Am J Kidney Dis. 1990;16:275–282
  29. Kasiske BL. Relationship between vascular disease and age-associated changes in the human kidney. Kidney Int. 1987;31:1153–1159
  30. Anderson S, Brenner BM. Effects of aging on the renal glomerulus. Am J Med. 1986;80:435–442
  31. Tan JC, Workeneh B, Busque S, et al. Glomerular function, structure, and number in renal allografts from older deceased donors. J Am Soc Nephrol. 2009;20:181–188
  32. Hemmelgarn BR, Zhang J, Manns BJ, et al. Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int. 2006;69:2155–2161
  33. Shlipak MG, Katz R, Kestenbaum B, et al. Rate of kidney function decline in older adults: A comparison using creatinine and cystatin C. Am J Nephrol. 2009;30:171–178
  34. Hsu CY, Ordoñez JD, Chertow GM, et al. The risk of acute renal failure in patients with chronic kidney disease. Kidney Int. 2008;74:101–107
  35. Schmitt R, Coco S, Kanbay M, et al. Recovery of kidney function after acute kidney injury in the elderly: A systematic review and meta-analysis. Am J Kidney Dis. 2008;52:262–271
  36. Mau LW, Liu J, Qiu Y, et al. Trends in patient characteristics and first-year medical costs of older incident hemodialysis patients, 1995-2005. Am J Kidney Dis. 2010;55:549–557
  37. Kurella Tamura M, Covinsky KE, Chertow GM, et al. Functional status of elderly adults before and after initiation of dialysis. N Engl J Med. 2009;361:1539–1547
  38. Thakar CV, Quate-Operacz M, Leonard AC, et al. Outcomes of hemodialysis patients in a long-term care hospital setting: A single-center study. Am J Kidney Dis. 2010;55:300–306
  39. Jassal SV, Watson D. Doc, don't procrastinate…Rehabilitate, palliate, and advocate. Am J Kidney Dis. 2010;55:209–212
  40. O'Hare AM, Choi AI, Bertenthai D, et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol. 2007;18:2758–2765
  41. Collins AJ, Foley RN, Herzog C, et al. United States renal data system 2008 annual data report abstract. Am J Kidney Dis. 2009;53(Suppl 1):A6–A7
  42. O'Hare AM, Glidden DC, Fox CS, et al. High prevalence of peripheral arterial disease in persons with renal insufficiency: Results from the National Health and Nutrition Examination Survey 1999-2000. Circulation. 2004;109:320–323
  43. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305
  44. Weiner DE, Tabatabai S, Tighiouart H, et al. Cardiovascular outcomes and all-cause mortality: Exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis. 2006;48:392–401
  45. O'Hare AM, Bertenthal D, Covinsky KE, et al. Mortality risk stratification in chronic kidney disease: One size for all ages?. J Am Soc Nephrol. 2006;17:846–853
  46. Ix JH, Shlipak MG, Chertow GM, et al. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: Data from the Heart and Soul Study. Circulation. 2007;115:173–179
  47. Kung HC, Hoyert DL, Xu J, et al. Deaths: Final data for 2005. Natl Vital Stat Rep. 2008;56:1–120
  48. Combe C, Albert JM, Bragg-Gresham JL, et al. The burden of amputation among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2009;54:680–692
  49. Knopman D, Boland LL, Mosley T, et al. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology. 2001;56:42–48
  50. Weiner DE, Bartolomei K, Scott T, et al. Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders. Am J Kidney Dis. 2009;53:438–447
  51. Barzilay JI, Fitzpatric AL, Luchsinger J, et al. Albuminuria and dementia in the elderly: A community study. Am J Kidney Dis. 2008;52:216–226
  52. Seliger SL, Siscovick DS, Stehman-Breen CO, et al. Moderate renal impairment and risk of dementia among older adults: The Cardiovascular Health Cognition Study. J Am Soc Nephrol. 2004;15:1904–1911
  53. Kim CD, Lee HJ, et al. High prevalence of leukoaraiosis in cerebral magnetic resonance images of patients on peritoneal dialysis. Am J Kidney Dis. 2007;50:98–107
  54. Murray AM, Tupper PR, Knopman DS, et al. Cognitive impairment in hemodialysis patients is common. Neurology. 2006;67:216–223
  55. O'Hare AM. The management of older adults with a low eGFR: Moving toward an individualized approach. Am J Kidney Dis. 2009;53:925–927
  56. Steinman MA, Landefeld CS, Rosenthal GE, et al. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc. 2006;54:516–523
  57. Fink JC, Brown J, Hsu VD, et al. CKD as an underrecognized threat to patient safety. Am J Kidney Dis. 2009;53:681–688
  58. Gooch K, Culleton BF, Manns BJ, et al. NSAID use and progression of chronic kidney disease. Am J Med. 2007;120:280.e1–280.e7
  59. Khurana A, McLean L, Atkinson S, et al. The effect of oral sodium phosphate drug products on renal function in adults undergoing bowel endoscopy. Arch Intern Med. 2008;168:593–597
  60. Einhorn LM, Zhan M, Hsu VD, et al. The frequency of hyperkalemia and its significance in chronic kidney disease. Arch Intern Med. 2009;169:1156–1162
  61. Moen MF, Zhan M, Hsu VD, et al. Frequency of hypoglycemia and its significance in chronic kidney disease. Clin J Am Soc Nephrol. 2009;4:1121–1127
  62. Stevens PE, O'Donoghue DJ. The UK model for system redesign and chronic kidney disease services. Semin Nephrol. 2009;29:475–482

PII: S1548-5595(10)00053-4

doi: 10.1053/j.ackd.2010.03.010

Advances in Chronic Kidney Disease
Volume 17, Issue 4 , Pages 293-301 , July 2010

Article Tools

* Image Usage & Resolution